Compile Data Set for Download or QSAR
Report error Found 81 for UniProtKB: P08519
TargetApolipoprotein(a)(Human)
Eli Lilly

US Patent
LigandPNGBDBM544455(3-[3-[[bis[[3-[2-carboxy-2-[(3R)-pyrrolidin-3-yl]p...)
Affinity DataIC50: 0.314nMAssay Description:The in vitro binding affinity of compounds to the intended target human Apo(a) protein is tested in a competitive binding assay. Human Apo(a) protein...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/16/2022
Entry Details
Go to US Patent

TargetApolipoprotein(a)(Human)
Eli Lilly

US Patent
LigandPNGBDBM544456((2S)-3-[3-[3-[(2S)-2-Carboxy-2-[(3R)-pyrrolidin-3-...)
Affinity DataIC50: 0.314nMAssay Description:The in vitro binding affinity of compounds to the intended target human Apo(a) protein is tested in a competitive binding assay. Human Apo(a) protein...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/16/2022
Entry Details
Go to US Patent

TargetApolipoprotein(a)(Human)
Eli Lilly

US Patent
LigandPNGBDBM544449((2S)-3-[3-[[Bis[[3-[(2S)-2-carboxy-2-[(3R)-pyrroli...)
Affinity DataIC50: 0.314nMAssay Description:The in vitro binding affinity of compounds to the intended target human Apo(a) protein is tested in a competitive binding assay. Human Apo(a) protein...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/16/2022
Entry Details
Go to US Patent

TargetLipoprotein(a) /B receptor(Human)
Tuojie Biotech (Shanghai) Co.

US Patent
LigandPNGBDBM717809(US20250042847, Compound 6)
Affinity DataIC50: 0.410nMAssay Description:Experimental steps: Equal amounts of Apo(a) and ApoB serum were mixed with a serially diluted test compound (highest concentration at 100 nM, seriall...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/11/2025
Entry Details
Go to US Patent

TargetApolipoprotein(a)(Human)
Eli Lilly

US Patent
LigandPNGBDBM747079(US20250179055, Compound 71)
Affinity DataIC50: 0.540nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/30/2025
Entry Details
Go to US Patent

TargetApolipoprotein(a)(Human)
Eli Lilly

US Patent
LigandPNGBDBM747087(US20250179055, Compound 96)
Affinity DataIC50: 0.580nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/30/2025
Entry Details
Go to US Patent

TargetApolipoprotein(a)(Human)
Eli Lilly

US Patent
LigandPNGBDBM747085(US20250179055, Compound 94)
Affinity DataIC50: 0.650nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/30/2025
Entry Details
Go to US Patent

TargetApolipoprotein(a)(Human)
Eli Lilly

US Patent
LigandPNGBDBM747118(US20250179055, Compound 139)
Affinity DataIC50: 0.660nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/30/2025
Entry Details
Go to US Patent

TargetApolipoprotein(a)(Human)
Eli Lilly

US Patent
LigandPNGBDBM747086(US20250179055, Compound 95)
Affinity DataIC50: 0.680nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/30/2025
Entry Details
Go to US Patent

TargetApolipoprotein(a)(Human)
Eli Lilly

US Patent
LigandPNGBDBM747114(US20250179055, Compound 135)
Affinity DataIC50: 0.710nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/30/2025
Entry Details
Go to US Patent

TargetApolipoprotein(a)(Human)
Eli Lilly

US Patent
LigandPNGBDBM747093(US20250179055, Compound 102)
Affinity DataIC50: 0.740nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/30/2025
Entry Details
Go to US Patent

TargetLipoprotein(a) /B receptor(Human)
Tuojie Biotech (Shanghai) Co.

US Patent
LigandPNGBDBM717800(US20250042847, Compound 1)
Affinity DataIC50: 0.75nMAssay Description:Experimental steps: Equal amounts of Apo(a) and ApoB serum were mixed with a serially diluted test compound (highest concentration at 100 nM, seriall...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/11/2025
Entry Details
Go to US Patent

TargetLipoprotein(a) /B receptor(Human)
Tuojie Biotech (Shanghai) Co.

US Patent
LigandPNGBDBM717810(US20250042847, Compound 7)
Affinity DataIC50: 0.760nMAssay Description:Experimental steps: Equal amounts of Apo(a) and ApoB serum were mixed with a serially diluted test compound (highest concentration at 100 nM, seriall...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/11/2025
Entry Details
Go to US Patent

TargetLipoprotein(a) /B receptor(Human)
Tuojie Biotech (Shanghai) Co.

US Patent
LigandPNGBDBM717808(US20250042847, Compound 5)
Affinity DataIC50: 0.780nMAssay Description:Experimental steps: Equal amounts of Apo(a) and ApoB serum were mixed with a serially diluted test compound (highest concentration at 100 nM, seriall...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/11/2025
Entry Details
Go to US Patent

TargetApolipoprotein(a)(Human)
Eli Lilly

US Patent
LigandPNGBDBM747119(US20250179055, Compound 140)
Affinity DataIC50: 0.790nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/30/2025
Entry Details
Go to US Patent

TargetApolipoprotein(a)(Human)
Eli Lilly

US Patent
LigandPNGBDBM747084(US20250179055, Compound 93)
Affinity DataIC50: 0.810nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/30/2025
Entry Details
Go to US Patent

TargetApolipoprotein(a)(Human)
Eli Lilly

US Patent
LigandPNGBDBM747082(US20250179055, Compound 90)
Affinity DataIC50: 0.830nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/30/2025
Entry Details
Go to US Patent

TargetApolipoprotein(a)(Human)
Eli Lilly

US Patent
LigandPNGBDBM747096(US20250179055, Compound 105)
Affinity DataIC50: 0.840nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/30/2025
Entry Details
Go to US Patent

TargetApolipoprotein(a)(Human)
Eli Lilly

US Patent
LigandPNGBDBM747081(US20250179055, Compound 81)
Affinity DataIC50: 0.850nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/30/2025
Entry Details
Go to US Patent

TargetApolipoprotein(a)(Human)
Eli Lilly

US Patent
LigandPNGBDBM747113(US20250179055, Compound 134)
Affinity DataIC50: 0.850nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/30/2025
Entry Details
Go to US Patent

TargetApolipoprotein(a)(Human)
Eli Lilly

US Patent
LigandPNGBDBM747089(US20250179055, Compound 98)
Affinity DataIC50: 0.850nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/30/2025
Entry Details
Go to US Patent

TargetLipoprotein(a) /B receptor(Human)
Tuojie Biotech (Shanghai) Co.

US Patent
LigandPNGBDBM717807(US20250042847, Compound 4)
Affinity DataIC50: 0.850nMAssay Description:Experimental steps: Equal amounts of Apo(a) and ApoB serum were mixed with a serially diluted test compound (highest concentration at 100 nM, seriall...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/11/2025
Entry Details
Go to US Patent

TargetApolipoprotein(a)(Human)
Eli Lilly

US Patent
LigandPNGBDBM747126(US20250179055, Compound 147)
Affinity DataIC50: 0.860nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/30/2025
Entry Details
Go to US Patent

TargetApolipoprotein(a)(Human)
Eli Lilly

US Patent
LigandPNGBDBM747077(US20250179055, Compound 65)
Affinity DataIC50: 0.870nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/30/2025
Entry Details
Go to US Patent

TargetApolipoprotein(a)(Human)
Eli Lilly

US Patent
LigandPNGBDBM747111(US20250179055, Compound 132)
Affinity DataIC50: 0.880nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/30/2025
Entry Details
Go to US Patent

TargetApolipoprotein(a)(Human)
Eli Lilly

US Patent
LigandPNGBDBM747073(US20250179055, Compound 11)
Affinity DataIC50: 0.890nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/30/2025
Entry Details
Go to US Patent

TargetApolipoprotein(a)(Human)
Eli Lilly

US Patent
LigandPNGBDBM747107(US20250179055, Compound 127)
Affinity DataIC50: 0.900nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/30/2025
Entry Details
Go to US Patent

TargetApolipoprotein(a)(Human)
Eli Lilly

US Patent
LigandPNGBDBM747125(US20250179055, Compound 146)
Affinity DataIC50: 0.930nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/30/2025
Entry Details
Go to US Patent

TargetApolipoprotein(a)(Human)
Eli Lilly

US Patent
LigandPNGBDBM747112(US20250179055, Compound 133)
Affinity DataIC50: 0.940nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/30/2025
Entry Details
Go to US Patent

TargetApolipoprotein(a)(Human)
Eli Lilly

US Patent
LigandPNGBDBM747090(US20250179055, Compound 99)
Affinity DataIC50: 0.960nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/30/2025
Entry Details
Go to US Patent

TargetApolipoprotein(a)(Human)
Eli Lilly

US Patent
LigandPNGBDBM747120(US20250179055, Compound 141)
Affinity DataIC50: 1.02nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/30/2025
Entry Details
Go to US Patent

TargetApolipoprotein(a)(Human)
Eli Lilly

US Patent
LigandPNGBDBM747100(US20250179055, Compound 111)
Affinity DataIC50: 1.02nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/30/2025
Entry Details
Go to US Patent

TargetApolipoprotein(a)(Human)
Eli Lilly

US Patent
LigandPNGBDBM747083(US20250179055, Compound 91)
Affinity DataIC50: 1.03nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/30/2025
Entry Details
Go to US Patent

TargetApolipoprotein(a)(Human)
Eli Lilly

US Patent
LigandPNGBDBM747075(US20250179055, Compound 47)
Affinity DataIC50: 1.03nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/30/2025
Entry Details
Go to US Patent

TargetApolipoprotein(a)(Human)
Eli Lilly

US Patent
LigandPNGBDBM747095(US20250179055, Compound 104)
Affinity DataIC50: 1.04nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/30/2025
Entry Details
Go to US Patent

TargetApolipoprotein(a)(Human)
Eli Lilly

US Patent
LigandPNGBDBM747070(US20250179055, Compound LY3473329)
Affinity DataIC50: 1.05nMMore data for this Ligand-Target Pair
Ligand InfoPDB
In Depth
Date in BDB:
9/30/2025
Entry Details
Go to US Patent
PDB3D3D Structure (crystal)
TargetApolipoprotein(a)(Human)
Eli Lilly

US Patent
LigandPNGBDBM747116(US20250179055, Compound 137)
Affinity DataIC50: 1.08nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/30/2025
Entry Details
Go to US Patent

TargetApolipoprotein(a)(Human)
Eli Lilly

US Patent
LigandPNGBDBM747091(US20250179055, Compound 100)
Affinity DataIC50: 1.12nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/30/2025
Entry Details
Go to US Patent

TargetApolipoprotein(a)(Human)
Eli Lilly

US Patent
LigandPNGBDBM747072(US20250179055, Compound 6)
Affinity DataIC50: 1.13nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/30/2025
Entry Details
Go to US Patent

TargetApolipoprotein(a)(Human)
Eli Lilly

US Patent
LigandPNGBDBM747099(US20250179055, Compound 108)
Affinity DataIC50: 1.16nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/30/2025
Entry Details
Go to US Patent

TargetApolipoprotein(a)(Human)
Eli Lilly

US Patent
LigandPNGBDBM747074(US20250179055, Compound 12)
Affinity DataIC50: 1.17nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/30/2025
Entry Details
Go to US Patent

TargetApolipoprotein(a)(Human)
Eli Lilly

US Patent
LigandPNGBDBM747102(US20250179055, Compound 113)
Affinity DataIC50: 1.17nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/30/2025
Entry Details
Go to US Patent

TargetApolipoprotein(a)(Human)
Eli Lilly

US Patent
LigandPNGBDBM747123(US20250179055, Compound 144)
Affinity DataIC50: 1.18nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/30/2025
Entry Details
Go to US Patent

TargetApolipoprotein(a)(Human)
Eli Lilly

US Patent
LigandPNGBDBM747110(US20250179055, Compound 131)
Affinity DataIC50: 1.19nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/30/2025
Entry Details
Go to US Patent

TargetApolipoprotein(a)(Human)
Eli Lilly

US Patent
LigandPNGBDBM747129(US20250179055, Compound 152)
Affinity DataIC50: 1.26nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/30/2025
Entry Details
Go to US Patent

TargetApolipoprotein(a)(Human)
Eli Lilly

US Patent
LigandPNGBDBM747106(US20250179055, Compound 126)
Affinity DataIC50: 1.26nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/30/2025
Entry Details
Go to US Patent

TargetApolipoprotein(a)(Human)
Eli Lilly

US Patent
LigandPNGBDBM747136(US20250179055, Compound 177)
Affinity DataIC50: 1.26nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/30/2025
Entry Details
Go to US Patent

TargetApolipoprotein(a)(Human)
Eli Lilly

US Patent
LigandPNGBDBM747108(US20250179055, Compound 128)
Affinity DataIC50: 1.34nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/30/2025
Entry Details
Go to US Patent

TargetApolipoprotein(a)(Human)
Eli Lilly

US Patent
LigandPNGBDBM747133(US20250179055, Compound 160)
Affinity DataIC50: 1.37nMMore data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
9/30/2025
Entry Details
Go to US Patent

TargetLipoprotein(a) /B receptor(Human)
Tuojie Biotech (Shanghai) Co.

US Patent
LigandPNGBDBM717806(US20250042847, Compound 3)
Affinity DataIC50: 1.40nMAssay Description:Experimental steps: Equal amounts of Apo(a) and ApoB serum were mixed with a serially diluted test compound (highest concentration at 100 nM, seriall...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
6/11/2025
Entry Details
Go to US Patent

Displayed 1 to 50 (of 81 total ) | Next | Last >>
Jump to: